Skip Nav Destination

First Edition

Research Article July 10 2025

A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLL

Min Guo,Tugba Memis,Alena Sophie Ehrmann,Anselm Pittrof,Bernd Baumann,Francesca Ferrante,Eugen Tausch,Kirsten Fischer,Hartmut Döhner,Tilman Borggrefe,Stephan Stilgenbauer,Ulrich Pannicke,Klaus Schwarz,Daniel Mertens,Franz Oswald

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 3 2025

Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS Trial

Davide Matino,Andrew Palladino,Carrie Turich Taylor,Eunhee Hwang,Sangeeta Raje,Satyaprakash Nayak,Regina McDonald,Suchitra Acharya,Johnny Mahlangu,Victor Jiménez-Yuste,Nirmalkumar G Choraria, Dr.,Renchi Yang,Chi-kong Li,Murtadha Al-Khabori,Yasser Ahmed Mohamed Soliman Wali,Javier De Jesus Morales-Adrian,Young-Shil Park,Osman Bülent Zülfikar,John Teeter

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article July 3 2025

Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails

Sinan Xiong,Jianbiao Zhou,Wee Joo Chng

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 3 2025

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

Bing Z Carter,Po Yee Mak,Edward Ayoub,Xiaogang Wu,Baozhen Ke,Yuki Nishida,Andrew Futreal,Lauren B Ostermann,Andrea D Bedoy,Steffen Boettcher,Courtney D. DiNardo,Anna Puzio-Kuter,Masha V Poyurovsky,Arnold J. Levine,Michael Andreeff

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 26 2025

Association of Epstein-Barr virus genomic alterations with human pathologies

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 25 2025

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome

Natalina Elliott,Neha Bhatnagar,Gemma Buck,David Cruz Hernandez,Kelly Perkins,Adam J. de Smith,Amélie Chaussade,Nizery Laure,Marlen Metzner,Garnett Catherine,Alice Norton,Kennedy Alison,Triya Chakravorty,Dylan Zhao,Lars Hanssen,Georgina W. Hall,Paresh Vyas,Irene Roberts

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 25 2025

Deciphering opsonized zymosan-induced phosphorylation of p47phox and NADPH oxidase activation in human neutrophils

Jie Liu,Coralie Pintard,Nathalie Thieblemont,Pham My-Chan Dang,Jamel El Benna

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 25 2025

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 25 2025

The endothelial mTORC2-Foxo1 axis serves as an iron-responsive sensor governing systemic iron homeostasis

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 25 2025

Plasminogen as a Ribonucleoprotein: Regulatory small RNA Cargo Modulates Fibrinolysis and Inflammation

Danielle L Michell,Clark Massick,Kaustubh S Koya,Ashley B Cavnar,Elizabeth M Semler,Chase Raby,Breanne H Y Gibson,Stephanie N Moore-Lotridge,Wanying Zhu,Marisol Ramirez-Solano,Quanhu Sheng,Ryan M Allen,MacRae F Linton,Jonathan G Schoenecker,Kasey Vickers

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 20 2025

Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell Lymphoma

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 12 2025

Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 11 2025

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article June 10 2025

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article May 15 2025

An Updated Understanding of Follicular Lymphoma Transformation

Erin M. Parry,Jessica Okosun

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article May 15 2025

How I Evaluate and Treat Resistance and Relapse in CML

Simona Soverini,Fausto Castagnetti

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article May 12 2025

How I approach hematopoietic stem cell transplantation for CML in a TKI world

Yves Chalandon,Federico Simonetta,Stavroula Masouridi-Levrat

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article April 16 2025

How I individualize treatment for chronic-phase CML

Ariel Monet Leyte-Vidal,Neil P. Shah

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article March 25 2025

How I treat chronic myeloid leukemia in children and adolescents

Jing Chen,Meinolf Suttorp,Nobuko Hijiya

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article March 16 2025

Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics

Ferran Araujo-Ayala,Wendy Béguelin

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article February 28 2025

The Future of Follicular Lymphoma Management: Strategies on the Horizon

Erin Mulvey,Sarah C. Rutherford,John P. Leonard

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article February 28 2025

End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?

Mengyang Di,Matthew J. Maurer,Christopher R. Flowers

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article January 27 2025

Frontline treatment of follicular lymphoma: What will it take to change current practice?

Emmanuel Bachy,Kim Linton

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Page 3 of 3

First Edition

A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLL

Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS Trial

Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

Association of Epstein-Barr virus genomic alterations with human pathologies

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome

Deciphering opsonized zymosan-induced phosphorylation of p47phox and NADPH oxidase activation in human neutrophils

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score

The endothelial mTORC2-Foxo1 axis serves as an iron-responsive sensor governing systemic iron homeostasis

Plasminogen as a Ribonucleoprotein: Regulatory small RNA Cargo Modulates Fibrinolysis and Inflammation

Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell Lymphoma

Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

An Updated Understanding of Follicular Lymphoma Transformation

How I Evaluate and Treat Resistance and Relapse in CML

How I approach hematopoietic stem cell transplantation for CML in a TKI world

How I individualize treatment for chronic-phase CML

How I treat chronic myeloid leukemia in children and adolescents

Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics

The Future of Follicular Lymphoma Management: Strategies on the Horizon

End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?

Frontline treatment of follicular lymphoma: What will it take to change current practice?

Email alerts

ASH Publications

American Society of Hematology

First Edition

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only